New guidance supports use of radiofrequency ablation for
osteoarthritic knee pain
ALPHARETTA, Ga., June 28, 2023 /PRNewswire/ -- Avanos Medical
supports the announcement today from the UK's National Institute
for Health and Care Excellence (NICE) recommending the use of
radiofrequency ablation (RFA) for the treatment of osteoarthritic
knee pain.
From the NICE announcement: "Radiofrequency energy is used to
denervate the target nerves. The radiofrequency energy can be
delivered as conventional radiofrequency, cooled radiofrequency or
pulsed radiofrequency. The aim is to reduce pain and delay the need
for knee arthroplasty. There is good evidence to show that this
procedure relieves pain in the short term. There are no major
safety concerns, and the complications, including numbness, are
well recognised."
"We are extremely pleased with today's interventional procedure
recommendation by NICE," commented Dieter
Krines, Avanos Vice President & General Manager,
Europe. "We look forward to
working with healthcare providers to offer this treatment option to
eligible patients across the UK."
Osteoarthritis is the most common form of arthritis, and for
patients who are not yet ready for surgery, Avanos' RFA pain
management products provide minimally invasive relief without the
use of opioids.
"The new interventional procedure recommendations published by
NICE is a great step forward to help adopt radiofrequency ablation
therapy for the treatment of osteoarthritic knee pain," said Dr.
Robin Correa, Consultant Pain
Management and Anaesthetics, University Hospitals Coventry and
Warwickshire (UHCW) NHS Trust. "Having observed the
transformation in the quality of life of patients under my
care using this treatment, I am delighted to see the publication of
the NICE recommendations. I hope this will now help
to increase awareness of this innovative therapy leading to
improved outcomes for many more patients."
Healthcare professionals and patients interested in learning
more about Avanos RFA pain management products should visit
https://avanos.co.uk/posts-uk/chronic-pain/interventional-procedures-recommendations-from-nice/
About Avanos Medical, Inc.
Avanos Medical, Inc. (NYSE:
AVNS) is a medical technology company focused on delivering
clinically superior medical device solutions that will help
patients get back to the things that matter. Headquartered in
Alpharetta, Georgia, we are
committed to addressing some of today's most important healthcare
needs, including providing a vital lifeline for nutrition to
patients from hospital to home, and reducing the use of opioids
while helping patients move from surgery to recovery. We develop,
manufacture and market our recognized brands globally and hold
leading market positions in multiple categories across our
portfolio. For more information, visit Avanos.com and follow Avanos
Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.
Logo -
https://mma.prnewswire.com/media/713850/Avanos_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/avanos-medical-supports-new-interventional-procedure-recommendations-from-the-uks-national-institute-of-health-and-care-excellence-nice-301866299.html